Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-protection provided by live Shigella mutants lacking major antigens.

International journal of medical microbiology : IJMM - 1 May 2013

Szijártó Valéria, Hunyadi-Gulyás Eva, Emődy Levente, Pál Tibor, Nagy Gábor

Abstract excerpt

The immune response elicited by Shigella infections is dominated by serotype-specific antibodies recognizing the LPS O-antigens. Although a marked antibody response to invasion plasmid antigens (Ipa-s) shared by all virulent strains is also induced, the varying level of immunity elicited by natural infections is serotype-restricted. Previous vaccines have tried to mimic and achieve this serotype-specific,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Bacterial
Share to Cross Protection
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Dysentery, Bacillary

Share to Gene Deletion

Share to Mice, Inbred BALB C

Share to Shigella

Share to Vaccines, Attenuated

Source

Identifiers

PMID: 23567193
DOI: 10.1016/j.ijmm.2013.02.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-protection provided by live Shigella mutants lacking major antigens.PMID 23567193Read ↗

An antibody targeting type III secretion system induces broad protection against Salmonella and Shigella infectionsSemantic proximity Read ↗

Status of vaccine research and development for ShigellaSemantic proximity Read ↗

Characterization of B-cell epitopes on IpaB, an invasion-associated antigen of Shigella flexneri: identification of an immunodominant domain recognized during natural infectionSemantic proximity Read ↗

The identification of novel immunogenic antigens as potential Shigella vaccine componentsSemantic proximity Read ↗

From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine’s Refinement and EvolutionSemantic proximity Read ↗

Animal models of shigellosis: a historical overviewSemantic proximity Read ↗

Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses.Semantic proximity Read ↗

Functional assays to evaluate antibody-mediated responses against Shigella: a reviewSemantic proximity Read ↗

The Shigella Vaccines PipelineSemantic proximity Read ↗

Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.Semantic proximity Read ↗

Outer membrane vesicles derived from <i>Salmonella</i> Typhimurium can deliver <i>Shigella flexneri</i> 2a O-polysaccharide antigen to prevent lethal pulmonary infection in miceSemantic proximity Read ↗

Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responsesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.